51 related articles for article (PubMed ID: 12804854)
1. Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach.
Barnett PV; Statham RJ; Vosloo W; Haydon DT
Vaccine; 2003 Jul; 21(23):3240-8. PubMed ID: 12804854
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Two Vaccines against Foot-and-Mouth Disease Used in Transcaucasian Countries by Small-Scale Immunogenicity Studies Conducted in Georgia, Azerbaijan and Armenia.
Foglia EA; Chaligava T; Aliyeva T; Kharatyan S; Tranquillo V; Pötzsch C; van Maanen C; Rosso F; Grazioli S; Brocchi E
Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543929
[TBL] [Abstract][Full Text] [Related]
3. An Alternative Serological Measure for Assessing Foot-and-Mouth Disease Vaccine Efficacy against Homologous and Heterologous Viral Challenges in Pigs.
Kim J; Lee SH; Kim HH; Shin SH; Park SH; Park JH; Park CK
Vaccines (Basel); 2023 Dec; 12(1):. PubMed ID: 38276669
[TBL] [Abstract][Full Text] [Related]
4. Maternally Derived Antibodies to Foot-and-Mouth Disease Virus Modulate the Antigenic Specificity of Humoral Responses in Vaccinated Cattle.
Senawi J; Wilsden G; Browning CFJ; Ludi AB; Ismail MM; Senin H; Gubbins S; King DP; Paton DJ
Vaccines (Basel); 2023 Dec; 11(12):. PubMed ID: 38140247
[TBL] [Abstract][Full Text] [Related]
5. The Immunogenicity of a Foot-and-Mouth Disease Virus Serotype O Vaccine in Commercial and Subsistence Cattle Herds in Zambia.
Banda F; Ludi AB; Wilsden G; Browning C; Kangwa HL; Mooya L; Ngoma M; Muuka GM; Mundia C; Fandamu P; Paton DJ; King DP; Quan M
Vaccines (Basel); 2023 Dec; 11(12):. PubMed ID: 38140222
[TBL] [Abstract][Full Text] [Related]
6. Humoral Immune Response in Calves Vaccinated with Monovalent Vaccines or a Trivalent Combination Thereof and Matching of These Vaccines to the Selected Circulating Foot-and-Mouth Disease Viruses in Ethiopia.
Woldemariyam FT; Negessu D; Bilata T; Muluneh A; Gebreweld DS; Ebisa IT; Paeshuyse J
Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631920
[TBL] [Abstract][Full Text] [Related]
7. Comparison of vaccination schedules for foot-and-mouth disease among cattle and sheep in Mongolia.
Ulziibat G; Raizman E; Lkhagvasuren A; Bartels CJM; Oyun-Erdene O; Khishgee B; Browning C; King DP; Ludi AB; Lyons NA
Front Vet Sci; 2023; 10():990043. PubMed ID: 37252379
[TBL] [Abstract][Full Text] [Related]
8. Predicting cross-protection against foot-and-mouth disease virus strains by serology after vaccination.
Gubbins S; Paton DJ; Dekker A; Ludi AB; Wilsden G; Browning CFJ; Eschbaumer M; Barnabei J; Duque H; Pauszek LL; King DP
Front Vet Sci; 2022; 9():1027006. PubMed ID: 36532344
[TBL] [Abstract][Full Text] [Related]
9. Viral dynamics and immune responses to foot-and-mouth disease virus in African buffalo (Syncerus caffer).
Perez-Martin E; Beechler B; Zhang F; Scott K; de Klerk-Lorist LM; Limon G; Dugovich B; Gubbins S; Botha A; Hetem R; van Schalkwyk L; Juleff N; Maree FF; Jolles A; Charleston B
Vet Res; 2022 Aug; 53(1):63. PubMed ID: 35927724
[TBL] [Abstract][Full Text] [Related]
10. Toward the calibration of serological assays using sera collected from cattle and sheep following a single dose of foot-and-mouth disease vaccine.
Karabassova AS; Sultanov AA; Saduakassova MA; King DP; Ludi AB; Browning CFJ; Wilsden G
Vet World; 2022 Feb; 15(2):524-530. PubMed ID: 35400944
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Potency and Duration of Immunity Elicited by a Multivalent FMD Vaccine for Use in South Africa.
Peta FRM; Sirdar MM; van Bavel P; Mutowembwa PB; Visser N; Olowoyo J; Seheri M; Heath L
Front Vet Sci; 2021; 8():750223. PubMed ID: 34977205
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of SAT2 Foot-and-Mouth Disease Vaccines Formulated with Montanide ISA 206B and Quil-A Saponin Adjuvants.
Rathogwa NM; Scott KA; Opperman P; Theron J; Maree FF
Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579233
[TBL] [Abstract][Full Text] [Related]
13. The selection of naturally stable candidate foot-and-mouth disease virus vaccine strains for East Africa.
Jackson B; Harvey Y; Perez-Martin E; Wilsden G; Juleff N; Charleston B; Seago J
Vaccine; 2021 Aug; 39(35):5015-5024. PubMed ID: 34303562
[TBL] [Abstract][Full Text] [Related]
14. The rescue and selection of thermally stable type O vaccine candidate strains of foot-and-mouth disease virus.
Gao Y; Li P; Ma X; Bai X; Sun P; Du P; Yuan H; Cao Y; Li K; Fu Y; Zhang J; Bao H; Chen Y; Li Z; Lu Z; Liu Z; Li D
Arch Virol; 2021 Aug; 166(8):2131-2140. PubMed ID: 34003358
[TBL] [Abstract][Full Text] [Related]
15. Immune response in dairy cattle against combined foot and mouth disease and haemorrhagic septicemia vaccine under field conditions.
Muenthaisong A; Rittipornlertrak A; Nambooppha B; Tankaew P; Varinrak T; Pumpuang M; Muangthai K; Atthikanyaphak K; Singhla T; Pringproa K; Punyapornwithaya V; Sawada T; Sthitmatee N
BMC Vet Res; 2021 May; 17(1):186. PubMed ID: 33952269
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of imported foot-and-mouth vaccines in different species in Mongolia.
Ulziibat G; Maygmarsuren O; Khishgee B; Basan G; Sandag B; Ruuragc S; Limon G; Wilsden G; Browning C; King DP; Ludi AB; Lyons NA
Vaccine; 2020 Feb; 38(7):1708-1714. PubMed ID: 31926753
[TBL] [Abstract][Full Text] [Related]
17. The antibody response induced FMDV vaccines in sheep correlates with early transcriptomic responses in blood.
Jouneau L; Lefebvre DJ; Costa F; Romey A; Blaise-Boisseau S; Relmy A; Jaszczyszyn Y; Dard-Dascot C; Déjean S; Versillé N; Guitton E; Hudelet P; Curet M; De Clercq K; Bakkali-Kassimi L; Zientara S; Klonjkowski B; Schwartz-Cornil I
NPJ Vaccines; 2020; 5(1):1. PubMed ID: 31908850
[TBL] [Abstract][Full Text] [Related]
18. Effects of regional differences and demography in modelling foot-and-mouth disease in cattle at the national scale.
Tsao K; Sellman S; Beck-Johnson LM; Murrieta DJ; Hallman C; Lindström T; Miller RS; Portacci K; Tildesley MJ; Webb CT
Interface Focus; 2020 Feb; 10(1):20190054. PubMed ID: 31897292
[TBL] [Abstract][Full Text] [Related]
19. Persistent Infection of African Buffalo (Syncerus caffer) with Foot-and-Mouth Disease Virus: Limited Viral Evolution and No Evidence of Antibody Neutralization Escape.
Cortey M; Ferretti L; Pérez-Martín E; Zhang F; de Klerk-Lorist LM; Scott K; Freimanis G; Seago J; Ribeca P; van Schalkwyk L; Juleff ND; Maree FF; Charleston B
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092573
[TBL] [Abstract][Full Text] [Related]
20. Chimeric O1K foot-and-mouth disease virus with SAT2 outer capsid as an FMD vaccine candidate.
Kotecha A; Perez-Martin E; Harvey Y; Zhang F; Ilca SL; Fry EE; Jackson B; Maree F; Scott K; Hecksel CW; Harmsen MM; Mioulet V; Wood B; Juleff N; Stuart DI; Charleston B; Seago J
Sci Rep; 2018 Sep; 8(1):13654. PubMed ID: 30209254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
